Cardinal Health is Monday's IBD Stock Of The Day. Shares are rebounding off their 21-day line, helped by continued biopharma momentum.

Cardinal Health stock is being upgraded to a buy rating, from my prior hold rating last year, agreeing with the SA analyst consensus today. Bullish drivers include recent revenue/earnings growth, ...

Cardinal Health (CAH) closed at $210.93 in the latest trading session, marking a +1.25% move from the prior day. The stock outpaced the S&P 500's daily gain of 0.5%. At the same time, the Dow added 0.

Cardinal Health (CAH) upgraded to Buy after a 100%+ run—see FY26 guidance, acquisitions, and nuclear medicine catalysts, plus ...

Feb 1 (Reuters) - Cardinal Health (CAH.N), opens new tab lowered the full-year profit forecast for its medical segment on Thursday, taking the shine off the company's upbeat second-quarter results and ...

Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's ...

We recently compiled a list of the 10 Best Investments During A Recession. Cardinal Health, Inc. is one of the best ...

DUBLIN, Ohio, June 4, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the U.S. launch of its multi-parameter, single-patient use monitoring cable and lead wire system that enables the ...

Narrow-moat Cardinal Health CAH reported better-than-expected results third-quarter results. Total sales were up 12.6% year over year driven by strong performance from its core distribution business.

Cardinal Health is building another warehouse in central Ohio as the wholesale drug distribution and medical supply company builds out capacity for the distribution for over-the-counter consumer ...

Cardinal Health, which manufactures and distributes medical and laboratory products, has entered into a definitive agreement to acquire Integrated Oncology Network, a physician-led independent ...